Skip to main content
TipRanks
Go Ultimate75% OFF

Revvity (PKN) Stock Price & Analysis

1 Followers

PKN Stock Chart & Stats

€136.60-€2.25(-1.62%)
At close: 5:30 PM GMT+1
€100€125€150Aug 24Sep 8Sep 21Oct 6Oct 20Nov 2Nov 16
Day’s Range
EUR 136.60 - EUR 140.05
52-Week Range
EUR 69.64 - EUR 151.10
Previous Close
EUR 138.85
Volume
N/A
Average Volume (3M)
125
Market Cap
EUR 15.12B
Enterprise Value
EUR 19.12B
Total Cash (Recent Filing)
EUR 592.80M
Total Debt (Recent Filing)
EUR 2.77B
Price to Earnings (P/E)
66.2
Beta
0.49
Next Earnings
Feb 04, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
0.18%

Bulls Say, Bears Say

Bulls Say

Software Recurring Growth

Strong Signals software growth and renewals add a recurring, workflow-embedded revenue stream that can improve customer retention and revenue visibility. New AI, logistics, and informatics products broaden the platform opportunity and may support durable expansion as adoption develops across laboratory customers.

Broad Growth And Margin Expansion

Growth across life sciences and diagnostics, combined with meaningful operating leverage, indicates that Revvity's transformation is improving the earnings profile. Raised growth, margin, and EPS guidance provides evidence that stronger demand and efficiency gains can persist beyond a single product or quarter.

Cash Generation And Deleveraging

High free-cash-flow conversion gives Revvity internal funding for product development, portfolio actions, and debt reduction. Fixed-rate debt, a long maturity profile, and declining leverage also strengthen financial resilience, allowing management to pursue strategic investments without relying heavily on near-term refinancing.

Bears Say

Compressed Profitability

Although earnings have recovered from the 2023 loss, profitability remains well below prior peaks and shareholder returns are modest. The lower earnings base means Revvity must sustain operational improvements and revenue growth to rebuild returns, while persistent margin compression could limit internally generated growth capacity.

Geographic Reproductive-health Pressure

Reproductive-health weakness in APAC, particularly amid challenging Chinese birth-rate conditions, creates a structural drag on part of the diagnostics portfolio. Continued pressure can reduce regional growth and make the company's overall performance more dependent on life sciences momentum and other geographies.

China Immunodiagnostics Divestiture

The pending divestiture addresses a business that is currently weighing on diagnostics margins, but it also changes Revvity's geographic and portfolio mix. Until closing, the unit remains a reported headwind, while the post-sale company will need replacement growth to offset the business being removed.

Revvity News

PKN FAQ

What was Revvity’s price range in the past 12 months?
Revvity lowest stock price was €69.64 and its highest was €151.10 in the past 12 months.
What is Revvity’s market cap?
Revvity’s market cap is €15.12B.
When is Revvity’s upcoming earnings report date?
Revvity’s next earnings report is estimated for Feb 04, 2027 (not yet confirmed), which is in 79 days.
How were Revvity’s earnings last quarter?
Revvity released its earnings results on Nov 03, 2026. The company reported €1.255 earnings per share for the quarter, beating the consensus estimate of €1.18 by €0.076.
Is Revvity overvalued?
According to Wall Street analysts Revvity’s price is currently Undervalued.
Does Revvity pay dividends?
Revvity does not currently pay dividends.
What is Revvity’s EPS estimate?
Revvity’s EPS estimate is 1.46.
How many shares outstanding does Revvity have?
Revvity has 111,638,756 shares outstanding.
What happened to Revvity’s price movement after its last earnings report?
Revvity reported an EPS of €1.255 in its last earnings report, beating expectations of €1.18. Following the earnings report the stock price went up 10.777%.
Which hedge fund is a major shareholder of Revvity?
Hedge funds hold Revvity shares: the largest hedge-fund position in Revvity is 1,732,151,969 shares, and hedge funds decreased their holdings by 328.0K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology